Nicholas Butowski

Nicholas Butowski

UNVERIFIED PROFILE

Are you Nicholas Butowski?   Register this Author

Register author
Nicholas Butowski

Nicholas Butowski

Publications by authors named "Nicholas Butowski"

Are you Nicholas Butowski?   Register this Author

100Publications

2753Reads

46Profile Views

The influence of race and socioeconomic status on therapeutic clinical trial screening and enrollment.

J Neurooncol 2020 Apr 29. Epub 2020 Apr 29.

Department of Neurological Surgery, University of California, 505 Parnassus Ave., Rm. M-779, San Francisco, CA, 94143-0112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-020-03503-xDOI Listing
April 2020

Attitudes toward fertility and fertility preservation in women with glioma.

Neurooncol Pract 2019 May 26;6(3):218-225. Epub 2018 Sep 26.

Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npy036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656302PMC
May 2019

Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60.

J Neurooncol 2019 Jan 29;141(2):383-391. Epub 2018 Nov 29.

Department of Neurological Surgery, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-018-03044-4DOI Listing
January 2019

Novel and Prospective Molecular Targets for Therapy of Intracranial Gliomas.

Prog Neurol Surg 2018 10;32:66-78. Epub 2018 Jul 10.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000469681DOI Listing
October 2018

Using genomics to guide treatment for glioblastoma.

Pharmacogenomics 2018 10 11;19(15):1217-1229. Epub 2018 Sep 11.

Department of Neurological Surgery, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2018-0078DOI Listing
October 2018

Primary brain tumours in adults.

Lancet 2018 08 27;392(10145):432-446. Epub 2018 Jul 27.

Department of Neurological Surgery, University of California, San Francisco, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01406736183099
Publisher Site
http://dx.doi.org/10.1016/S0140-6736(18)30990-5DOI Listing
August 2018

MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis.

AJR Am J Roentgenol 2018 Mar 20;210(3):621-628. Epub 2017 Dec 20.

1 Department of Radiology and Biomedical Imaging, University of California, San Francisco, 350 Parnassus, 370H, San Francisco, CA 94143.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.17.18457DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823758PMC
March 2018

Clinical trial endpoints for patients with gliomas.

Neurooncol Pract 2017 Dec 14;4(4):201-208. Epub 2017 Feb 14.

Department of Neurological Surgery, University of California San Francisco, San Francisco, California (J.W.T., A.M.M., N.B., M.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npw034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655446PMC
December 2017

Early tumor growth between initial resection and radiotherapy of glioblastoma: incidence and impact on clinical outcomes.

J Neurooncol 2017 Aug 31;134(1):213-219. Epub 2017 May 31.

Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-017-2511-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563441PMC
August 2017

Chordoid glioma of the third ventricle: report of a rapidly progressive case.

J Neurooncol 2017 05 18;132(3):487-495. Epub 2017 Mar 18.

Departments of Pathology and Laboratory Medicine, Emory University Hospital, H-195, 1364 Clifton Rd. NE, Atlanta, GA, 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-017-2399-7DOI Listing
May 2017

The Effect of Molecular Diagnostics on the Treatment of Glioma.

Curr Oncol Rep 2017 Apr;19(4):26

Division of Neuro-Oncology, Department of Neurological Surgery, University of California, 400 Parnassus Ave, A808, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-017-0585-6DOI Listing
April 2017

A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma.

Cancer Chemother Pharmacol 2017 03 23;79(3):603-610. Epub 2017 Feb 23.

Division of Neuro-oncology, Department of Neurological Surgery, University of California, San Francisco (UCSF), 505 Parnassus Avenue M779, San Francisco, CA, 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-017-3247-3DOI Listing
March 2017

Treatment options for recurrent high-grade gliomas.

CNS Oncol 2017 01 21;6(1):61-70. Epub 2016 Dec 21.

Department of Neurological Surgery, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cns-2016-0013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027924PMC
January 2017

Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma.

J Neurooncol 2016 12 8;130(3):571-579. Epub 2016 Nov 8.

Neuro-Oncology Branch, CCR, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2263-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571739PMC
December 2016

The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients with High-grade Glioma.

Acad Radiol 2016 09 18;23(9):1073-82. Epub 2016 Jul 18.

Department of Radiology and Biomedical Imaging, Neuroradiology Section, University of California, Box 0628 Bldg 350 Parnassus Ave, Room 307, San Francisco, CA 94143; Department of Neurological Surgery, University of California, San Francisco, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2016.04.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571825PMC
September 2016

Interventional MRI-guided catheter placement and real time drug delivery to the central nervous system.

Expert Rev Neurother 2016 06 20;16(6):635-9. Epub 2016 Apr 20.

a Department of Neurological Surgery , University of California, San Francisco , San Francisco , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737175.2016.1175939DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553275PMC
June 2016

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study.

Neuro Oncol 2016 Apr 8;18(4):557-64. Epub 2015 Oct 8.

University of California at San Francisco, San Francisco, California (N.B., A.P., J.P., A.M.M, M.P.); Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (H.C.); The University of Texas MD Anderson Cancer Center, Houston, Texas (J.F.D.G.); Department of Neurology, Memorial Sloan Kettering Cancer Hospital, New York, New York (A.M.O.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (L.N., P.Y.W., S.H., K.L.L.); UCLA Medical Center, Los Angeles, California (T.F.C.); Plexxikon Inc., Berkeley, California (A.M., B.L.W., K.B.N., H.H.H.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (K.L.L.); Department of Pathology, Memorial Sloan Kettering Cancer Hospital, New York, New York (J.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov245DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799682PMC
April 2016

In Reply: Survival With Glioblastoma Multiforme and the Timing of Chemoradiation.

Neurosurgery 2016 Feb;78(2):E315

Department of Neurological Surgery, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0000000000001078DOI Listing
February 2016

The effects of anti-angiogenic therapy on the formation of radiation-induced microbleeds in normal brain tissue of patients with glioma.

Neuro Oncol 2016 Jan 22;18(1):87-95. Epub 2015 Jul 22.

Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California (J.M.L., E.E.-B., S.C., S.J.N.); Department of Neurosurgery, University of California San Francisco, San Francisco, California (A.M.M., N.B., S.M.C., S.C.); Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California (A.M.M.); Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California (S.J.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677411PMC
January 2016

Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience.

J Neurooncol 2016 Jan;126(1):193-200

Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, 450 Brookline Ave, D1622, Boston, MA, 02215-5418, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-015-1959-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826306PMC
January 2016

Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials.

Transl Oncol 2015 Dec;8(6):446-55

Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA United States; UCSF/UCB Joint Graduate Group in Bioengineering, University of California, San Francisco, San Francisco, CA United States; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2015.10.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700297PMC
December 2015

Central Nervous System Cancers, Version 1.2015.

J Natl Compr Canc Netw 2015 Oct;13(10):1191-202

From University of Alabama at Birmingham Comprehensive Cancer Center; City of Hope Comprehensive Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Yale Cancer Center/Smilow Cancer Hospital; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; The University of Texas MD Anderson Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Washington/Seattle Cancer Care Alliance; Roswell Park Cancer Institute; Duke Cancer Institute; UC San Diego Moores Cancer Center; University of Michigan Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; St. Jude Children's Research Hospital/University of Tennessee Health Science Center; Massachusetts General Hospital Cancer Center; American Brain Tumor Association; Vanderbilt-Ingram Cancer Center; Mayo Clinic Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Stanford Cancer Institute; Fred & Pamela Buffet Cancer Center; Huntsman Cancer Institute at the University of Utah; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Moffitt Cancer Center; Fox Chase Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/13/10/1191.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2015.0148DOI Listing
October 2015

Neurocognitive Function in Newly Diagnosed Low-grade Glioma Patients Undergoing Surgical Resection With Awake Mapping Techniques.

Neurosurgery 2015 Sep;77(3):371-9; discussion 379

*Department of Neurological Surgery, University of California at San Francisco, San Francisco, California; ‡Department of Epidemiology & Biostatistics, University of California at San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0000000000000779DOI Listing
September 2015

The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma.

Neurosurgery 2015 Aug;77(2):248-53; discussion 253

Departments of *Neurological Surgery, ‡Epidemiology and Biostatistics, and §Neurology, University of California at San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0000000000000766DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506198PMC
August 2015

Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence.

Neurosurgery 2015 Aug;62 Suppl 1:160-5

*Department of Neurological Surgery, ‡Department of Epidemiology and Biostatistics, and §Department of Neurology, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0000000000000801DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260825PMC
August 2015

Epidemiology and diagnosis of brain tumors.

Continuum (Minneap Minn) 2015 Apr;21(2 Neuro-oncology):301-13

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.CON.0000464171.50638.faDOI Listing
April 2015

Familial gliomas: cases in two pairs of brothers.

J Neurooncol 2015 Jan 11;121(1):135-40. Epub 2014 Sep 11.

Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Ave., Rm M779, San Francisco, CA, 94143-0112, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-014-1611-2DOI Listing
January 2015

NT113, a pan-ERBB inhibitor with high brain penetrance, inhibits the growth of glioblastoma xenografts with EGFR amplification.

Mol Cancer Ther 2014 Dec 13;13(12):2919-29. Epub 2014 Oct 13.

Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. Northwestern Medicine Developmental Therapeutics Institute, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-14-0306DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364529PMC
December 2014

Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines.

J Natl Compr Canc Netw 2014 Nov;12(11):1517-23

From University of Alabama at Birmingham Comprehensive Cancer Center; City of Hope Comprehensive Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; The University of Texas MD Anderson Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Washington/Seattle Cancer Care Alliance; Memorial Sloan Kettering Cancer Center; Roswell Park Cancer Institute; Duke Cancer Institute; UC San Diego Moores Cancer Center; American Brain Tumor Association; University of Michigan Comprehensive Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Massachusetts General Hospital Cancer Center; Vanderbilt-Ingram Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Stanford Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; Huntsman Cancer Institute at the University of Utah; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Moffitt Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337873PMC
http://dx.doi.org/10.6004/jnccn.2014.0151DOI Listing
November 2014

Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma.

Neuro Oncol 2014 Sep 26;16(9):1255-62. Epub 2014 Mar 26.

Department of Neurological Surgery, University of California, San Francisco, California (S.J.H., J.D.R., A.M.M., J.L.C., M.D.P., S.M.C., M.S.B., A.D., N.A.B.); Department of Epidemiology and Biostatistics, University of California, San Francisco, California (A.M.M.).

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nou044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136897PMC
September 2014

Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial.

Neuro Oncol 2014 Jan 12;16(2):274-9. Epub 2013 Dec 12.

Corresponding Author: Andrew T. Parsa, MD, PhD, Professor and Chair, Department of Neurological Surgery, Northwestern University, Feinberg School of Medicine, 676 N. St. Clair Street, Suite 2210, Chicago, IL 60611.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895386PMC
January 2014

A roundtable discussion on the clinical challenges and options for the treatment of glioblastoma: introducing a novel modality, TTFields.

Semin Oncol 2013 Dec 10;40(6):S2-4. Epub 2013 Oct 10.

Neuro Oncology, Keck Medical Center of USC, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2013.10.002DOI Listing
December 2013

Disseminated progression of glioblastoma after treatment with bevacizumab.

Clin Neurol Neurosurg 2013 Sep 21;115(9):1795-801. Epub 2013 May 21.

Department of Neurological Surgery, Brain Tumor Research Center, University of California, San Francisco, CA 94143-0112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clineuro.2013.04.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565209PMC
September 2013

Endpoints for clinical trials and revised assessment in neuro-oncology.

Curr Opin Neurol 2012 Dec;25(6):780-5

Division of Neuro- Oncology, Department of Neurological Surgery, University of California San Francisco, San Francisco, California 94143-0350, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0b013e328359b45eDOI Listing
December 2012

General and neurological complications of targeted therapy.

Handb Clin Neurol 2012 ;105:937-45

Department of Neurological Surgery, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-444-53502-3.00033-1DOI Listing
April 2012

Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment.

Neurosurgery 2012 Feb;70(2):361-70

Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94143-0112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0b013e3182314f9dDOI Listing
February 2012

Conditional probability of survival in patients with newly diagnosed glioblastoma.

J Clin Oncol 2011 Nov 3;29(31):4175-80. Epub 2011 Oct 3.

Biometric Research Branch, National Cancer Institute, National Institute of Health, Room 8124, Executive Plaza North, 6130 Executive Blvd, Rockville, MD 20892, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2010.32.4343
Publisher Site
http://dx.doi.org/10.1200/JCO.2010.32.4343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208537PMC
November 2011

Identifying the needs of brain tumor patients and their caregivers.

J Neurooncol 2011 Sep 11;104(3):737-44. Epub 2011 Feb 11.

Division of Neuro-Oncology in the Department of Neurosurgery, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-011-0534-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170122PMC
September 2011

Impact of bevacizumab chemotherapy on craniotomy wound healing.

J Neurosurg 2011 Jun 10;114(6):1609-16. Epub 2010 Dec 10.

Department of Neurological Surgery, University of California, San Francisco, California 94143-0112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2010.10.JNS101042DOI Listing
June 2011

Anti-angiogenic therapy in glioma.

Clin Transl Oncol 2011 May;13(5):294-300

Department of Neuro-Oncology, Brain Tumor Research Center, University of California, San Francisco, CA 94143-0350, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12094-011-0657-2DOI Listing
May 2011

Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma.

Neuro Oncol 2011 Jan 29;13(1):119-31. Epub 2010 Oct 29.

Department of Radiology and Biomedical Imaging, University of California-San Francisco, UCSF Mail Code 2532, Byers Hall Room #303, 1700 4th Street, San Francisco, CA 94158-0223, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/noq143DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018901PMC
January 2011

Medical management of brain metastases.

Neurosurg Clin N Am 2011 Jan;22(1):27-36, v-vi

Department of Neurological Surgery, University of California, 400 Parnassus Avenue # 0372, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nec.2010.08.004DOI Listing
January 2011

Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme.

Neuro Oncol 2010 Sep 25;12(9):908-16. Epub 2010 May 25.

UCSF/UCB Joint Graduate Group in Bioengineering, Department of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, California 94158-2330, USA.

View Article

Download full-text PDF

Source
http://old.radiology.ucsf.edu/sites/all/files/filemanager/Ne
Web Search
http://neuro-oncology.oxfordjournals.org/cgi/doi/10.1093/neu
Publisher Site
http://dx.doi.org/10.1093/neuonc/noq049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940691PMC
September 2010

Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study.

Neuro Oncol 2010 Jun 15;12(6):608-13. Epub 2010 Feb 15.

Department of Neurological Surgery, University of California San Francisco, 400 Parnassus Avenue, A808, San Francisco, CA 94143-0350, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nop070DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940647PMC
June 2010

Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide.

Neuro Oncol 2010 Mar 21;12(3):274-82. Epub 2009 Dec 21.

Brain Tumor Research Center, Department of Neurological Surgery, University of California-San Francisco, 400 Parnassus Avenue, Room A-808, Box 0372, San Francisco, California 94143-2167, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nop034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940590PMC
March 2010

Recent advances in therapy for glioblastoma.

Arch Neurol 2010 Mar;67(3):279-83

Division of Neuro-Oncology, Department of Neurological Surgery, University of California, San Francisco, 400 Parnassus Ave, Room A-808, Box 0372, San Francisco, CA 94143-0372, USA.

View Article

Download full-text PDF

Source
http://archneur.jamanetwork.com/article.aspx?doi=10.1001/arc
Publisher Site
http://dx.doi.org/10.1001/archneurol.2010.5DOI Listing
March 2010

Immunostimulants for malignant gliomas.

Neurosurg Clin N Am 2010 Jan;21(1):53-65

Department of Neurological Surgery, University of California San Francisco, 400 Parnassus Avenue, A808, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nec.2009.08.007DOI Listing
January 2010

Quality of life in low-grade glioma patients receiving temozolomide.

Neuro Oncol 2009 Feb 19;11(1):59-68. Epub 2008 Aug 19.

Department of Medicine, Division of Hematology/Oncology/Neuro-Oncology, University of California, San Francisco, CA 94143-2167, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1215/15228517-2008-063DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2718960PMC
February 2009

Longitudinal magnetic resonance imaging features of glioblastoma multiforme treated with radiotherapy with or without brachytherapy.

Int J Radiat Oncol Biol Phys 2008 Dec 4;72(5):1340-6. Epub 2008 Jun 4.

Department of Radiology, University of California-San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.02.078DOI Listing
December 2008

Preoperative prognostic classification system for hemispheric low-grade gliomas in adults.

J Neurosurg 2008 Nov;109(5):817-24

Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/JNS/2008/109/11/0817DOI Listing
November 2008

Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme.

J Neurooncol 2007 Oct 25;85(1):87-94. Epub 2007 Apr 25.

Neuro-Oncology Service, Department of Neurological Surgery, University of California, San Francisco, 400 Parnassus Avenue, A808, San Francisco, CA 94143-0350, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-007-9388-1
Publisher Site
http://dx.doi.org/10.1007/s11060-007-9388-1DOI Listing
October 2007

Glial tumors: the current state of scientific knowledge.

Clin Neurosurg 2006 ;53:106-13

Department of Neurological Surgery, University of California, San Francisco, USA.

View Article

Download full-text PDF

Source
May 2007

Therapeutic advances for glioblastoma multiforme: current status and future prospects.

Curr Oncol Rep 2007 Jan;9(1):66-70

University of Wisconsin Comprehensive Cancer Center, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02951428DOI Listing
January 2007

Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme.

Neurosurg Focus 2006 Apr 15;20(4):E4. Epub 2006 Apr 15.

Department of Neurological Surgery, University of California, San Francisco, California 94143-0350, USA.

View Article

Download full-text PDF

Source
April 2006

Diagnosis and treatment of recurrent high-grade astrocytoma.

J Clin Oncol 2006 Mar;24(8):1273-80

Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94143-0350, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.04.7522DOI Listing
March 2006

Small molecule and monoclonal antibody therapies in neurooncology.

Cancer Control 2005 Apr;12(2):116-24

Department of Neurological Surgery, University of California, San Francisco, CA 94143-0350, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/107327480501200207DOI Listing
April 2005